Aarti Drugs Ltd board approves raising of upto Rs. 350 crores

The Board of Directors of Aarti Drugs Ltd, at its meeting held on today, has passed an enabling resolution for raising of funds by way of issue of equity shares or any other instruments or security including fully/partly convertible debentures or by way of a composite issue of non-convertible debentures and warrants entitling the warrant holder(s) to apply for equity shares or any other eligible securities through qualified institutions placement, private placement/public issue of equity/debt securities, preferential issue or through any other permissible mode and/or combination thereof as may be considered appropriate, subject to such approvals as may be required including the approval of the members at a general meeting or through postal ballot and further subject to such other statutory/regulatory approvals, as applicable for an aggregate amount of upto Rs. 350 Crores (Rupees Three hundred and Fifty Crores).

Shares of AARTI DRUGS LTD. was last trading in BSE at Rs.748.75 as compared to the previous close of Rs. 749.4. The total number of shares traded during the day was 102017 in over 7172 trades.

The stock hit an intraday high of Rs. 769.95 and intraday low of 740. The net turnover during the day was Rs. 76864842.

Source : Equity Bulls

Keywords